The angiotensin II type 2 receptor in the brain

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 1, 2010, Pages 1-6

  Horiuchi, Masatsugu ^a   Mogi, Masaki ^a   Iwai, Masaru ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; AT2 receptor; Brain; Cognitive function; Stroke

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; METHYL METHANESULFONATE SENSITIVE 2; SMALL INTERFERING RNA; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG; VALSARTAN;

BRAIN DAMAGE; BRAIN ISCHEMIA; CELL SURVIVAL; CELL THERAPY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; HUMAN; HYPERTENSION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STROKE; STROMA CELL;

BRAIN; BRAIN ISCHEMIA; COGNITION; HUMANS; NEURONS; RECEPTOR, ANGIOTENSIN, TYPE 2; STROKE;

EID: 77749298333     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309347793     Document Type: Review

References (56)

1. de Gasparo M., Catt KJ, Inagami T., Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000 ; 52: 415-472.
2. Jöhren O., Imboden H., Hätsignuser W., Mayer I., Sanvitto GL, Saavedra JM Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus. Brain Res 1997 ; 757: 218-227.
3. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000 ; 106: 103-106.
4. Davisson RL, Yang G., Beltz TG, Cassell MD, Jhonson AK, Sigmund CD The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 1998 ; 83: 1047-1058.
5. Li Z., Iwai M., Wu L. et al. Role of AT2 receptor in the brain in regulation of blood pressure and water intake. Am J Physiol Heart Circ Physiol 2003 ; 284: H116-21.
6. Dahlöf B., Devereux RB, Kjeldsen SE et al.; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 ; 359: 995-1003. (Pubitemid 34286536)
7. Lithell H., Hansson L., Skoog I. et al.; SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003 ; 21: 875-886. (Pubitemid 36677151)
8. Schiffrin EL Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study. Curr Hypertens Rep 2002 ; 4: 39-40.
9. Mochizuki S., Dahlöf B., Shimizu M. et al.; Jikei Heart Study Group. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007 ; 369: 1431-1439.
10. Steckelings UM, Kaschina E., Unger T. The AT2 receptor- a matter of love and hate. Peptides 2005 ; 26: 1401-1409.
11. Lucius R., Gallinat S., Rosenstiel P., Herdegan T., Sievers J., Unfer T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 1998 ; 188: 661-670.
12. Wright JW, Reichert JR, Davis CJ, Hatding JW Neural plasticity and the brain renin-angiotensin system. Neurosci Biobehav Rev 2002 ; 26: 529-552.
13. Vervoort VS, Beachem MA, Edwards PS et al. AGTR2 mutations in X-linked mental retardation. Science 2002 ; 296: 2401-2403.
14. Maeda K., Hata R., Bader M., Walther T., Hossmann KA Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion. J Cereb Blood Flow Metab 1999 ; 19: 1092-1098. (Pubitemid 30167759)
15. Walther T., Olah L., Christoph H. et al. Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 2002 ; 16: 169-176.
16. Iwai M., Liu HW, Chen R. et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004 ; 110: 843-848.
17. Wright JW, Harding JW Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept 1995 ; 59: 269-295.
18. Zhu YZ, Chimon GN, Zhu YC et al. Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats. Neuroreport 2000 ; 11: 1191-1194.
19. Reinecke K., Lucius R., Reinecke A., Rickert U., Herdegen T., Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J 2003 ; 17: 2094-2096.
20. Li J., Culman J., Hortnagl H. et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 2005 ; 19: 617-619.
21. Gendron L., Laflamme L., Rivard N., Asselin C., Payet MD, Gallo-Payet N. Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol Endocrinol 1999 ; 13: 1615-1626.
22. Cote F., Laflamme L., Payet MD, Gallo-Payet N. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res 1998 ; 24: 403-407.
23. Cote F., Do TH, Laflamme L., Gallo JM, Gallo-Payet N. Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 1999 ; 274: 31686-31692.
24. Mogi M., Li JM, Iwanami J. et al. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006 ; 48: 141-148.
25. Moraes TF, Edwards RA, McKenna S. et al. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat Struct Biol 2001 ; 8: 669-673.
26. VanDemark AP, Hofmann RM, Tsui C., Pickart CM, Wolberger C. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 2001 ; 105: 711-720.
27. Hofmann RM, Pickart CM Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 1999 ; 96: 645-653.
28. Chopp M., Chan PH, Hsu CY, Cheung ME, Jacobs TP DNA damage and repair in central nervous system injury: National Institute of Neurological Disorders and Stroke Workshop Summary. Stroke 1996 ; 27: 363-369.
29. Hofsaess U., Kapfhammer JP Identification of numerous genes differentially expressed in rat brain during postnatal development by suppression subtractive hybridization and expression analysis of the novel rat gene rMMS2. Brain Res Mol Brain Res 2003 ; 113: 13-27.
30. Li JM, Mogi M., Tsukuda K. et al. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptorinteracting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 2007 ; 21: 499-511.
31. Laflamme L., Gasparo M., Gallo JM, Payet MD, Gallo-Payet N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem 1996 ; 271: 22729-22735.
32. Meffert S., Stoll M., Steckelings UM, Bottari SP, Unger T. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 1996 ; 122: 59-67. (Pubitemid 26328859)
33. Hein L., Barsh GS, Pratt RE, Dzau VJ, Kobilka BK Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995 ; 377: 744-747.
34. Ichiki T., Labosky PA, Shiota C. et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995 ; 377: 748-750.
35. Nouet S., Amzallag N., Li JM et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004 ; 279: 28989-28997.
36. Wruck CJ, Funke-Kaiser H., Pufe T. et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 2005 ; 25: 57-64.
37. Seibold S., Rudroff C., Weber M., Galle J., Wanner C., Marx M. Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 2003 ; 17: 1180-1182.
38. Vambutas V., Kaplan DR, Sells MA, Chernoff J. Nerve growth factor stimulates tyrosine phosphorylation and activation of Src homology-containing protein-tyrosine phosphatase 1 in PC12 cells. J Biol Chem 1995 ; 270: 25629-25633.
39. Lyden D., Young AZ, Zagzag D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999 ; 401: 670-677.
40. Andersen PL, Zhou H., Pastushok L. et al. Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A. J Cell Biol 2005 ; 170: 745-755.
41. Shen LH, Li Y., Chen J. et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007 ; 27: 6-13.
42. Zhao MZ, Nonoguchi N., Ikeda N. et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 2006 ; 26: 1176-1188.
43. Kelly S., Bliss TM, Shah AK et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004 ; 101: 11839-11844.
44. Hayashi J., Takagi Y., Fukuda H. et al. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab 2006 ; 26: 906-914.
45. Willing AE, Lixian J., Milliken M. et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 2003 ; 73: 296-307.
46. Caplan AI, Bruder SP Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001 ; 7: 259-264.
47. Phinney DG Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl 2002 ; 38: 7-12.
48. Chopp M., Zhang XH, Li Y. et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000 ; 11: 3001-3005.
49. Nakano K., Migita M., Mochizuki H., Shimada T. Differentiation of transplanted bone marrow cells in the adult mouse brain. Transplantation 2001 ; 71: 1735-1740. (Pubitemid 32622483)
50. Li Y., Chen J., Wang L., Lu M., Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001 ; 56: 1666-1672. (Pubitemid 32574564)
51. Li Y., Chen J., Chen XG et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002 ; 59: 514-523.
52. Chen X., Katakowski M., Li Y. et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002 ; 69: 687-691. (Pubitemid 34966882)
53. Chen X., Li Y., Wang L. et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002 ; 22: 275-279.
54. Li Y., Chopp M., Chen J. et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000 ; 20: 1311-1319.
55. Rempe DA, Kent TA Using bone marrow stromal cells for treatment of stroke. Neurology 2002 ; 59: 486-487.
56. Iwanami J., Mogi M., Li JM et al. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008 ; 39: 2254-2259.